Acute and relapsing experimental autoimmune encephalomyelitis in IL-4- and α/β T cell-deficient C57BL/6 mice

Journal of Neuroimmunology

Volumn 87, Issue 1-2, 1998, Pages 171-178

  Zhao, Ming Lang ^a   Fritz, Robert B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Experimental autoimmune encephalomyelitis; IL 4; Mice; Myelin oligodendrocyte glycoprotein peptide; T cells

Indexed keywords

INTERLEUKIN 4;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ARTICLE; CHRONIC DISEASE; IMMUNE DEFICIENCY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RELAPSE; T LYMPHOCYTE;

ACUTE DISEASE; ANIMALS; CELL TRANSPLANTATION; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERLEUKIN-4; MALE; MICE; MICE, INBRED C57BL; MYELIN-ASSOCIATED GLYCOPROTEIN; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECURRENCE; SPLEEN; T-LYMPHOCYTES;

EID: 0032126944     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00083-6     Document Type: Article

References (35)

1. Ando, D.G., Clayton, J., Kono, D., Urban, J.L., Sercarz, E.E., 1989. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell. Immunol. 124, 132-143.
2. Bonetti, B., Pohl, J., Gao, Y.-L., Raine, C.S., 1997. Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J. Immunol. 159, 5733-5741.
3. Chen, Y., Kuchroo, V.K., Inobe, J., Hafler, D.A., Weiner, H.L., 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237-1240.
4. + T cells are resistant to the induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 70, 139-144.
5. Fierz, W., Heininger, K., Schaefer, B., Toyka, K.V., Linington, C., Lassmann, H., 1988. Synergism in the pathogenesis of EAE induced by an MBP-specific T-cell line and monoclonal antibodies to galacto-cerebroside or a myelin oligodendroglial glycoprotein. Ann. N.Y. Acad. Sci. 540, 360-363.
6. Fritz, R.B., Chou, C.H., McFarlin, D.E., 1983. Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. J. Immunol. 130, 1024-1026.
7. Fritz, R.B., Perry, L.L., Chou, C.H., 1984. Genetic control of myelin basic protein-induced experimental allergic encephalomyelitis in mice. Prog. Clin. Biol. Res. 146, 235-242.
8. Fritz, R.B., Skeen, M.J., Chou, C.H., Garcia, M., Egorov, I.K., 1985. Major histocompatibility complex-linked control of the murine immune response to myelin basic protein. J. Immunol. 134, 2328-2332.
9. Holda, J.A., Welch, A.M., Swanborg, R.H., 1980. Autoimmune effector cells: I. Transfer of experimental allergic encephalomyelitis with lymphoid cells cultured with antigen. Eur. J. Immunol. 10, 657-659.
10. Kennedy, M.K., Torrance, D.S., Ficha, K.S., Mohler, K.M., 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149, 2496-2505.
11. Khoruts, A., Miller, S.D., Jenkins, M.K., 1995. Neuroantigen-specific Th2 T cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells. J. Immunol. 155, 5011-5017.
12. Khoury, S., Hancock, J., Weiner, H.L., 1992. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with down-regulation of inflammatory cytokines and differential up-regulation of transforming growth factor b, interleukin 4, and prostaglandin E in the brain. J. Exp. Med. 176, 1355-1364.
13. Kopf, M., LeGros, G., Bachmann, M., Lamers, M.C., Bluethmann, H., Kohler, G., 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362, 245-248.
14. Kuhn, R., Rajewsky, K., Muller, W., 1991. Generation and analysis of interleukin-4 deficient mice. Science 254, 707-710.
15. Kumar, V., Coulsell, E., Ober, B., Hubbard, G., Sercarz, E., Ward, E.S., 1997. Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells. J. Immunol. 159, 5150-5156.
16. Lafaille, J.J., Nagashima, K., Katsuki, M., Tonegawa, S., 1994. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78, 399-408.
17. Lafaille, J.J., Van de Keere, F., Hsu, A.L., Baron, J.L., Haas, W., Raine, C.S., Tonegawa, S., 1997. Myelin basic protein-specific helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from disease. J. Exp. Med. 186, 307-312.
18. Liblau, R., Steinman, L., Brocke, S., 1997. Experimental autoimmune encephalomyelitis in IL-4-deficient mice. Int. Immunol. 9, 799-803.
19. Marusic, S., Tonegawa, S., 1997. Tolerance induction and autoimmune encephalomyelitis amelioration after administration of myelin basic protein peptide. J. Exp. Med. 186, 507-515.
20. + T lymphocytes in the spinal cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein. J. Neurol. Sci. 139, 1-6.
21. Mendel, I., Kerlero de Rosbo, N., Ben-Nun, A., 1995. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitisin H-2b mice: fine specificity and T cell receptor beta expression of encephalitogenic T cells. Eur. J. Immunol. 25, 1951-1959.
22. Mendel, I., Kerlero de Rosbo, N., Ben-Nun, A., 1996. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice. Eur. J. Immunol. 26, 2470-2479.
23. Mieza, M., Itoh, T., Cui, J.Q., Makino, Y., Kawano, T., Tsuchida, K., Koike, T., Shirai, T., Yagita, H., Matsuzawa, A., Koseki, H., Taniguchi, M., 1996. Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 156, 4035-4040.
24. Nagelkerken, L., Blauw, B., Tielmans, M., 1997. IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice. Int. Immunol. 9, 1243-1251.
25. Panitch, H., McFarlin, D., 1977. Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by Concanavalin A. J. Immunol. 119, 1134.
26. Peters, B.A., Hinrichs, D.J., 1982. Passive transfer of experimental allergic encephalomyelitis in the Lewis rat with activated spleen cells: differential activation with mitogens. Cell. Immunol. 69, 175-185.
27. - T lymphocytes. J. Immunol. 127, 1420.
28. Powell, M.B., Mitchell, D., Lederman, J., Buckmeier, J., Zamvil, S.S., Graham, M., Ruddle, N.H., Steinman, L., 1990. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2, 539-544.
29. Racke, M.K., Bonomo, A., Scott, D.E., Cannella, B., Levine, A., Raine, C.S., Shevach, E.M., Rocken, M., 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180, 1961-1966.
30. Sabelko, K.A., Kelly, K.A., Nahm, M.H., Cross, A.M., Russell, J.H., 1997. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J. Immunol. 159, 3096-3099.
31. Sakai, K., Namikawa, T., Kunishita, T., Yamanouchi, K., Tabira, T., 1986. Studies of experimental allergic encephalomyelitis by using encephalitogenic T cell lines and clones in euthymic and athymic mice. J. Immunol. 137, 1527-1531.
32. Taniguchi, M., Makino, Y., Cui, J., Masuda, K., Kawano, T., Sato, H., Kondo, E., Koseki, H., 1996. V alpha 14+ NK T cells: a novel lymphoid cell lineage with regulatory function. J. Allergy Clin. Immunol. 98.
33. Waksman, B., Morrison, L., 1951. Tuberculin type sensitivity to spinal cord antigen in rabbits with issoallergic encephalomyelitis. J. Immunol. 66, 421.
34. Wolf, S.D., Dittel, B.N., Hardardottir, F., Janeway, C.A. Jr., 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184, 2271-2278.
35. Zhang, B., Yamamura, T., Kondo, T., Fujiwara, M., Tabira, T., 1997. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186, 1677-1687.